Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 8/2007

01.08.2007 | Original Paper

Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer

verfasst von: Shigeki Umemura, Yoshihiko Segawa, Hiroshi Ueoka, Katsuyuki Hotta, Katsuyuki Kiura, Nagio Takigawa, Masahiro Tabata, Akihiro Bessho, Tetsu Shinkai, Mitsune Tanimoto

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 8/2007

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study is to elucidate the influence of serum arginine-vasopressin (AVP) level on prognosis of extensive-disease small-cell lung cancer (ED-SCLC).

Methods

We retrospectively investigated the clinical records of 163 patients with ED-SCLC, who were admitted to Okayama University Hospital or National Shikoku Cancer Center Hospital. The influence of 14 pretreatment variables on survival was analyzed.

Results

In a multivariate analysis of 163 patients, elevation of serum LDH level (P = 0.028) and poor performance status (PS ≥ 2, P = 0.002) were independent poor prognostic factors. In 34 patients whose serum AVP levels were available, high serum AVP level was related to the poor prognosis (P < 0.001). The serum-sodium level did not affect the survival. Median serum level of osmotic pressure in 34 patients was normal (284.9 mOsm/kg), although, serum osmotic pressure was low in four of six patients with high serum AVP level. In all patients with high serum AVP level, serum LDH level was elevated.

Conclusions

The data from the current study suggested that serum LDH level and PS were the poor prognostic factors for ED-SCLC. But we additionally identified the prognostic significance of serum AVP level, which may be a more useful factor than serum-sodium level.
Literatur
Zurück zum Zitat Albain KS, Crowley JJ, LeBlanc M, Livingston RB (1990) Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group database. J Clin Oncol 8:1563–1574PubMed Albain KS, Crowley JJ, LeBlanc M, Livingston RB (1990) Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group database. J Clin Oncol 8:1563–1574PubMed
Zurück zum Zitat American Joint Committee on Cancer (2002) Lung, AJCC Cancer Staging Manual, 6th edn. Springer, New York, pp 167–177 American Joint Committee on Cancer (2002) Lung, AJCC Cancer Staging Manual, 6th edn. Springer, New York, pp 167–177
Zurück zum Zitat Bliss DP Jr, Battey JF, Linnoila RI, Birrer MJ, Gazdar AF, Johnson BE (1990) Expression of the atrial natriuretic factor gene in small cell lung cancer tumors and tumor cell lines. J Natl Cancer Inst 82:305–310PubMedCrossRef Bliss DP Jr, Battey JF, Linnoila RI, Birrer MJ, Gazdar AF, Johnson BE (1990) Expression of the atrial natriuretic factor gene in small cell lung cancer tumors and tumor cell lines. J Natl Cancer Inst 82:305–310PubMedCrossRef
Zurück zum Zitat Boring CC, Squires TS, Tong T, Montgomery S (1994) Cancer statistics. CA Cancer J Clin 44:7–26PubMed Boring CC, Squires TS, Tong T, Montgomery S (1994) Cancer statistics. CA Cancer J Clin 44:7–26PubMed
Zurück zum Zitat Byhardt RW, Hartz A, Libnoch JA, Hansen R, Cox JD (1986) Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCLC). Int J Radiat Oncol Biol Phys 12:771–777PubMed Byhardt RW, Hartz A, Libnoch JA, Hansen R, Cox JD (1986) Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCLC). Int J Radiat Oncol Biol Phys 12:771–777PubMed
Zurück zum Zitat Cerny T, Blair V, Anderson H, Branwell V, Thatcher N (1987) Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer 39:146–149PubMedCrossRef Cerny T, Blair V, Anderson H, Branwell V, Thatcher N (1987) Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer 39:146–149PubMedCrossRef
Zurück zum Zitat Dropcho EJ (1995) Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options. Ann Neurol 37(Suppl 1):S102–S113PubMedCrossRef Dropcho EJ (1995) Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options. Ann Neurol 37(Suppl 1):S102–S113PubMedCrossRef
Zurück zum Zitat Ferlay J, Bray F, Parkin DM, Pisani P (2001) Globocan 2000: cancer incidence, mortality and prevalence worldwide, Version 1.0. IARC Cancer Bases No.5. IARC, Lyon Ferlay J, Bray F, Parkin DM, Pisani P (2001) Globocan 2000: cancer incidence, mortality and prevalence worldwide, Version 1.0. IARC Cancer Bases No.5. IARC, Lyon
Zurück zum Zitat Ganz PA, Ma PY, Wang HJ, Elashoff RM (1987) Evaluation of three biochemical markers for serially monitoring the therapy of small cell lung cancer. J Clin Oncol 5:472–479PubMed Ganz PA, Ma PY, Wang HJ, Elashoff RM (1987) Evaluation of three biochemical markers for serially monitoring the therapy of small cell lung cancer. J Clin Oncol 5:472–479PubMed
Zurück zum Zitat Harper PG, Souhami RL, Spiro SG, Geddes DM, Guimaraes M, Fearon F, Smyth JF (1982) Tumour size, response rate and prognosis in small-cell lung carcinoma of the bronchus treated by combination chemotherapy. Cancer Treat Rep 66:463–470PubMed Harper PG, Souhami RL, Spiro SG, Geddes DM, Guimaraes M, Fearon F, Smyth JF (1982) Tumour size, response rate and prognosis in small-cell lung carcinoma of the bronchus treated by combination chemotherapy. Cancer Treat Rep 66:463–470PubMed
Zurück zum Zitat Johnson BE, Chute JP, Rushin J, Williams J, Le PT, Venzon D, Richardson GE (1997) A prospective study of patients with lung cancer and hyponatremia of malignancy. Am J Respir Crit Care Med 156:1669–1678PubMed Johnson BE, Chute JP, Rushin J, Williams J, Le PT, Venzon D, Richardson GE (1997) A prospective study of patients with lung cancer and hyponatremia of malignancy. Am J Respir Crit Care Med 156:1669–1678PubMed
Zurück zum Zitat Johnson BE, Damodaran A, Rushin J, Gross A, Le PT, Chen HC, Harris RB (1997) Ectopic production and processing of atrial natriuretic peptide in a small cell lung carcinoma cell line and tumor from a patient with hyponatremia. Cancer 79:35–44PubMedCrossRef Johnson BE, Damodaran A, Rushin J, Gross A, Le PT, Chen HC, Harris RB (1997) Ectopic production and processing of atrial natriuretic peptide in a small cell lung carcinoma cell line and tumor from a patient with hyponatremia. Cancer 79:35–44PubMedCrossRef
Zurück zum Zitat Jorgensen LG, Osterlind K, Genolla J, Gomm SA, Hernandez JR, Johnson PW, Lober J, Splinter TA, Szturmowicz M (1996) Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres. Br J Cancer 74:463–467PubMed Jorgensen LG, Osterlind K, Genolla J, Gomm SA, Hernandez JR, Johnson PW, Lober J, Splinter TA, Szturmowicz M (1996) Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres. Br J Cancer 74:463–467PubMed
Zurück zum Zitat Kamoi K, Ebe T, Hasegawa A, Sato F, Takato H, Iwamoto H, Kaneko H, Ishibashi M, Yamaji T (1987) Hyponatremia in small cell lung cancer. Mechanisms involving inappropriate ADH secretion. Cancer 60:1089–1093PubMedCrossRef Kamoi K, Ebe T, Hasegawa A, Sato F, Takato H, Iwamoto H, Kaneko H, Ishibashi M, Yamaji T (1987) Hyponatremia in small cell lung cancer. Mechanisms involving inappropriate ADH secretion. Cancer 60:1089–1093PubMedCrossRef
Zurück zum Zitat Kawahara M, Fukuoka M, Saijo N, Nishiwaki Y, Ikegami H, Tamura T, Shimoyama M, Suemasu K, Furuse K (1997) Prognostic factors and prognostic staging system for small cell lung cancer. Jpn J Clin Oncol 27:158–165PubMedCrossRef Kawahara M, Fukuoka M, Saijo N, Nishiwaki Y, Ikegami H, Tamura T, Shimoyama M, Suemasu K, Furuse K (1997) Prognostic factors and prognostic staging system for small cell lung cancer. Jpn J Clin Oncol 27:158–165PubMedCrossRef
Zurück zum Zitat List AF, Hainsworth JD, Davis BW, Hande KR, Greco FA, Johnson DH (1986) The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer. J Clin Oncol 4:1191–1198PubMed List AF, Hainsworth JD, Davis BW, Hande KR, Greco FA, Johnson DH (1986) The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer. J Clin Oncol 4:1191–1198PubMed
Zurück zum Zitat Mason WP, Graus F, Lang B, Honnorat J, Delattre JY, Valldeoriola F, Antoine JC, Rosenblum MK, Rosenfeld MR, Newsom-Davis J, Posner JB, Dalmau J (1997) Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 120(Pt 8):1279–1300PubMedCrossRef Mason WP, Graus F, Lang B, Honnorat J, Delattre JY, Valldeoriola F, Antoine JC, Rosenblum MK, Rosenfeld MR, Newsom-Davis J, Posner JB, Dalmau J (1997) Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 120(Pt 8):1279–1300PubMedCrossRef
Zurück zum Zitat Morstyn G, Ihde DC, Lichter AS, Bunn PA, Carney DN, Glatstein E, Minna JD (1984) Small cell lung cancer 1973–1983: early progress and recent obstacles. Int J Radiat Oncol Biol Phys 10:515–539PubMed Morstyn G, Ihde DC, Lichter AS, Bunn PA, Carney DN, Glatstein E, Minna JD (1984) Small cell lung cancer 1973–1983: early progress and recent obstacles. Int J Radiat Oncol Biol Phys 10:515–539PubMed
Zurück zum Zitat North WG (1991) Neuropeptide production by small cell lung carcinoma: vasopressin and oxytocin as plasma markers of disease. J Clin Endocrinol Metab 73:1316–1320PubMed North WG (1991) Neuropeptide production by small cell lung carcinoma: vasopressin and oxytocin as plasma markers of disease. J Clin Endocrinol Metab 73:1316–1320PubMed
Zurück zum Zitat Osterlind K, Anderson PK (1986) Prognostic factors in small cell lung cancer: a multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res 46:4189–4194PubMed Osterlind K, Anderson PK (1986) Prognostic factors in small cell lung cancer: a multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res 46:4189–4194PubMed
Zurück zum Zitat Paesmans M, Sculier JP, Lecomte J, Thiriaux J, Libert P, Sergysels R, Bureau G, Dabouis G, Van Cutsem O, Mommen P, Ninane V, Klastersky J (2000) Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years. Cancer 9:523–533CrossRef Paesmans M, Sculier JP, Lecomte J, Thiriaux J, Libert P, Sergysels R, Bureau G, Dabouis G, Van Cutsem O, Mommen P, Ninane V, Klastersky J (2000) Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years. Cancer 9:523–533CrossRef
Zurück zum Zitat Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer statistics. CA Cancer J Clin 47:5–27PubMed Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer statistics. CA Cancer J Clin 47:5–27PubMed
Zurück zum Zitat Sagman U, Maki E, Evans WK, Warr D, Shepherd FA, Sculier JP, Haddad R, Payne D, Pringle JF, Yeoh JL (1991) Small-cell carcinoma of the lung: derivation of a prognostic staging system. J Clin Oncol 9:1639–1649PubMed Sagman U, Maki E, Evans WK, Warr D, Shepherd FA, Sculier JP, Haddad R, Payne D, Pringle JF, Yeoh JL (1991) Small-cell carcinoma of the lung: derivation of a prognostic staging system. J Clin Oncol 9:1639–1649PubMed
Zurück zum Zitat Seute T, Leffers T, ten Velde GP, Twijnstra A (2004) Neurologic disorders in 432 consecutive patients with small cell lung carcinoma. Cancer 100:801–806PubMedCrossRef Seute T, Leffers T, ten Velde GP, Twijnstra A (2004) Neurologic disorders in 432 consecutive patients with small cell lung carcinoma. Cancer 100:801–806PubMedCrossRef
Zurück zum Zitat Singh S, Parulekar W, Murray N, Feld R, Evans WK, Tu D, Shepherd FA (2005) Influence of sex on toxicity and treatment outcome in small-cell lung cancer. J Clin Oncol 23:850–856PubMedCrossRef Singh S, Parulekar W, Murray N, Feld R, Evans WK, Tu D, Shepherd FA (2005) Influence of sex on toxicity and treatment outcome in small-cell lung cancer. J Clin Oncol 23:850–856PubMedCrossRef
Zurück zum Zitat Sorensen JB, Andersen MK, Hansen HH (1995) Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Intern Med 238:97–110PubMedCrossRef Sorensen JB, Andersen MK, Hansen HH (1995) Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Intern Med 238:97–110PubMedCrossRef
Zurück zum Zitat Spiegelman D, Maurer LH, Ware JH, Perry MC, Chahinian AP, Comis R, Eaton W, Zimmer B, Green M (1989) Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients. J Clin Oncol 7:344–354PubMed Spiegelman D, Maurer LH, Ware JH, Perry MC, Chahinian AP, Comis R, Eaton W, Zimmer B, Green M (1989) Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients. J Clin Oncol 7:344–354PubMed
Zurück zum Zitat Tai P, Yu E, Jones K, Sadikov E, Mahmood S, Tonita J (2006) Syndrome of inappropriate antidiuretic hormone secretion (SIADH) in patients with limited stage small cell lung cancer. Lung Cancer 53:211–215PubMedCrossRef Tai P, Yu E, Jones K, Sadikov E, Mahmood S, Tonita J (2006) Syndrome of inappropriate antidiuretic hormone secretion (SIADH) in patients with limited stage small cell lung cancer. Lung Cancer 53:211–215PubMedCrossRef
Zurück zum Zitat Thatcher N, Faivre-Finn C, Lorigan P (2005) Lung cancer: management of small-cell lung cancer. Ann Oncol 16(Suppl 2):ii235–ii239PubMedCrossRef Thatcher N, Faivre-Finn C, Lorigan P (2005) Lung cancer: management of small-cell lung cancer. Ann Oncol 16(Suppl 2):ii235–ii239PubMedCrossRef
Zurück zum Zitat Williams CL (1997) Basic science of small cell lung cancer. Chest Surg Clin N Am 7:1–15PubMed Williams CL (1997) Basic science of small cell lung cancer. Chest Surg Clin N Am 7:1–15PubMed
Zurück zum Zitat Yip D, Harper PG (2000) Predictive and prognostic factors in small cell lung cancer: current status. Lung cancer 28:173–185PubMedCrossRef Yip D, Harper PG (2000) Predictive and prognostic factors in small cell lung cancer: current status. Lung cancer 28:173–185PubMedCrossRef
Zurück zum Zitat Zerbe R, Stropes L, Robertson G (1980) Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 31:315–327PubMedCrossRef Zerbe R, Stropes L, Robertson G (1980) Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 31:315–327PubMedCrossRef
Metadaten
Titel
Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer
verfasst von
Shigeki Umemura
Yoshihiko Segawa
Hiroshi Ueoka
Katsuyuki Hotta
Katsuyuki Kiura
Nagio Takigawa
Masahiro Tabata
Akihiro Bessho
Tetsu Shinkai
Mitsune Tanimoto
Publikationsdatum
01.08.2007
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 8/2007
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-007-0196-y

Weitere Artikel der Ausgabe 8/2007

Journal of Cancer Research and Clinical Oncology 8/2007 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.